Navigation Links
Microbicides could serve to materialise women empowerment in the years to come

Microbicides are a broad range of user-controlled products that would help women protect themselves from sexually transmitted diseases including AIDS.// It can be developed in any form that is convenient to use such as a gel, cream, film or suppository.

These microbicides will enable women to negotiate condom use or to abandon partners who put them at risk and would also help avoid unwanted pregnancies, according to experts. With such products coming up, women empowerment will acquire new meaning in Tamil Nadu in a few months’ time when the third phase of the clinical trials for at least three candidate microbicides will begin. The Indian Council of Medical Research (ICMR), a premier research institution, is already studying a product called “Praneem”.

The existing violence, force and economic dependency render millions of women unable to negotiate condom use or abandon partners who put them at risk. This applies to all age group categories. Ultimately women end up with no choice but to give in. Furthermore, it is difficult to encourage male partners to use condoms.

There are currently no approved microbicides in large-scale use worldwide yet. In 2001, WHO declared nonoxylon-9 products, attempts of which turned out be a failure.

It is said that even 60 percent effective microbicides can prevent 2.5 million new HIV infections in the next three years, and this trial is important as the HIV vaccine is still 10 years away. Researchers world over are working on 60 products and half a dozen candidate microbicides are in the last stages of clinical trial, some in India.

In India, microbicide trials will be carried out by the ICMR in collaboration with an US research agency CONRAD, with which the central government has signed a MoU in 2004.

Source: Indo-Asian News Servic
'"/>




Page: 1

Related medicine news :

1. Computer Tool Predicts Effectiveness Of Microbicides
2. Microbicides, Need of the Hour, to Aid the Fight Against HIV
3. Virus Level could Predict Cervical Cancer Risk
4. Beware of the oral patch! It could be cancer!!!
5. Prozac miracle could end in disaster
6. Wonder drug - could end in disaster
7. Pollution could be a risk
8. Fright could be more harmful
9. Pregnant smokers could harm their child
10. Snoring could be a warning
11. Anthrax drug doxycycline could stunt fetal growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: